FY2026(1st quarter) Supplementary Material of Financial Results

Consolidated Financial Results for the Three Months Ended June 30, 2026(Based on Japanese GAAP)

Notice of Completion of Payment for the Issuance of 1st Series Class A Preferred Shares through Third-Party Allotment and Taking Effect of Reduction of Amounts of Share Capital and Legal Capital Surplus

Acquisition of Shares of Tanabe Pharma Factory Co., Ltd. and Transfer of Manufacturing and Marketing Approvals

Notice of Completion of Payment for Disposal of Treasury Shares as Restricted Stock Compensation